Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal ADCYAP1 Primary Antibody for ELISA, WB - ABIN4343354
Bourgault, Vaudry, Botia, Couvineau, Laburthe, Vaudry, Fournier: Novel stable PACAP analogs with potent activity towards the PAC1 receptor. in Peptides 2008
The temporal and spatial expression pattern of the ghrh-pacap1 transcript suggests that thise hormones may modulate patterning during development.
expression of transcripts for PACAP (show VIPR2 Antibodies) and its receptors by 0.5-6 hpf make both PACAP1 and PACAP2 candidates for factors that influence brain development
study reveals the distribution of immunoreactive GHRH (show GHRH Antibodies)-like peptide in structures of the zebrafish brain; results suggest involvement of GHRH (show GHRH Antibodies)-LP in both neuroendocrine and feeding-associated nervous circuits
age-related changes were observed in the PACAP KO mice only. These alterations included horizontal and rod bipolar cell dendritic sprouting into the photoreceptor layer and decreased ganglion cell number. Also, Muller glial cells showed elevated GFAP (show GFAP Antibodies) expression compared to the aging WT retinas.
Mice lacking endogenous PACAP have slower weight gain during the first weeks of development and slower neurobehavioral development.
Study investigated effects of chronic variable mild stress (CVMS) in non-injected, vehicle and imipramine-treated KO mice vs. wildtype (WT) counterparts and mapped the CVMS-related FosB (show FOSB Antibodies) response in 18 brain areas; found that PACAP deficiency affects neuronal reactivity in a brain area-specific manner in stress centers
Backup mechanisms maintain PACAP/VIP (show Vip Antibodies)-induced arterial vasodilation in PACAP-deficient mice.
PACAP/PAC1 (show ADCYAP1R1 Antibodies) signaling has a role in light regulated food anticipatory activity
PACAP deficient mice exhibit attenuated acute restraint stress response and chronic restraint stress response.
not only homozygous but also heterozygous PACAP deficient mice are more vulnerable to kidney ischemia/reperfusion, further supporting the nephroprotective effects of the endogenous PACAP
PACAP expression in the dorsal root ganglion following spinal nerve injury is controlled through transcriptional repressor, REST.
This study demonstrated that Human mesenchymal stem/stromal cells suppress spinal inflammation in mice with contribution of pituitary adenylate cyclase-activating polypeptide.
PACAP shows morphological actions via its cognate receptor PAC1 (show ADCYAP1R1 Antibodies).
Study found that interictal serum PACAP levels are not increased (or decreased) in a large series of chronic migraine women when compared to matched controls without a headache history
Study found a protective effect of PACAP-38 on oxidative stress damage in zebrafish hair cells, suggesting PACAP-38 ability to prevent hair cells from apoptosis. PACAP-38 treatment decreased the cleaved caspase-3 (show CASP3 Antibodies) level in the hair cells, but somewhat unexpectedly had no influence on p-38 MAPK (show MAPK1 Antibodies) pathway. PACAP-38 treatment also rescued H2O2-induced reduction in movement.
Low MZB1 (show MZB1 Antibodies) expression was an independent prognostic factor for recurrence after curative gastrectomy and was associated significantly with increased hematogenous recurrence. MZB1 (show MZB1 Antibodies) acts as a suppressor of GC. Low MZB1 (show MZB1 Antibodies) expression in the primary GC tissue is predictive of recurrence after curative resection.
An association was found in a common variant of the PACAP receptor in patients with cluster headache.
PACAP-38 is released in plasma during attacks of episodic cluster headache patients.
Hypermethylation of ADCYAP1 gene may be highly associated with the development of cervical cancer.
This review provides an overview of current knowledge regarding the neuroprotective effects, mechanisms of action, and therapeutic potential of PACAP in response to ischemic brain injuries
PACAP is involved in the pathogenesis of migraine rather than tension-type headache
PACAP38-PAC1 (show ADCYAP1R1 Antibodies) signaling process initiates bone marrow-derived cells homing into the ischemic brain for reducing brain injury.
Results suggest that PACAP could protect SH-SY5Y dopaminergic cells against toxicity induced by inflammatory mediators.
High level of co-expression of PACAP with VIP (show Vip Antibodies), SP and CGRP (show CALCA Antibodies) in the distal ganglia of the vagus sensory perikarya directly implicates studied peptides in their functional interaction during nociceptive vagal transduction.
PACAP (show MZB1 Antibodies) stimulates secretoneurin (show SCG2 Antibodies) release and secretogranin II (show SCG2 Antibodies) gene transcription in bovine adrenochromaffin cells
This gene encodes a secreted proprotein that is further processed into multiple mature peptides. These peptides stimulate adenylate cyclase and increase cyclic adenosine monophosphate (cAMP) levels, resulting in the transcriptional activation of target genes. The products of this gene are key mediators of neuroendocrine stress responses. Alternative splicing results in multiple transcript variants.
glucagon family neuropeptides
, growth hormone-releasing hormone
, pituitary adenylate cyclase-activating polypeptide
, pituitary adenylate cyclase activating polypeptide
, adenylate cyclase activating peptide, pituitary 1
, type I adenylate cyclase activating polypeptide receptor
, adenylate cyclase activating polypeptide 1 (pituitary)
, pituitary adenylate cyclase activating polypeptide 1
, pituitary adenylate cyclase-activating polypeptide precursor (Pacap)
, pituitary adenylate cyclase activating polypeptide, PACAP